Results 41 to 50 of about 5,741,783 (179)

Hip Tenosynovial Giant Cell Tumor without Recurrence in a 9-Year Follow-Up

Case Reports in Orthopedics, 2022
Background. Tenosynovial giant cell tumors are a benign but rare condition with potentially aggressive tumor-like traits which should be considered in young patients with monoarticular joint involvement. Case Presentation.
Seyyed-Morteza Kazemi, Seyyed-Mohsen Hosseininejad   +1 more
doaj   +1 more source

The Knee Tenosynovial Giant Cell Tumor: A Deceptive Case Report with Non-Specific Presentations

Journal of Orthopedic and Spine Trauma, 2023
Objective: Tenosynovial giant cell tumor (TGCT) is a rare hyperplastic condition of the joint’s synovial membrane with a high recurrence and tumor-like characteristics affecting large joints such as the hip, knee, and ankle. They often present with dull
Seyyed-Mohsen Hosseininejad, Seyyed-Morteza Kazemi   +1 more
doaj   +1 more source

Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor [PDF]

, 2010
Tenosynovial giant cell tumor is a neoplastic disease of joints that can cause severe morbidity. Recurrences are common following local therapy, and no effective medical therapy currently exists.
Gao, Doris, Yuzhuo Wang, Wang, Y.Z., West, Robert, Paul W. Clarkson, Clarkson, Paul, Torsten O. Nielsen, Cheng, Hongwei, Hongwei Cheng, Dongxia Gao, Abraham, Judith, Marina Pacheco, Nielsen, Torsten   +12 more
core   +2 more sources

Malignant Tenosynovial Giant Cell Tumor Presenting as an Extra-Articular Superficial Soft-Tissue Mass in a Knee

대한영상의학회지, 2022
Malignant tenosynovial giant cell tumor (TsGCT) is a rare disease that can arise as a recurrent lesion or co-exist with a benign TsGCT lesion. Here we report a rare case of malignant TsGCT in a 73-year-old male with a history of lymphoma.
Jimin Lee, In Sook Lee, You Seon Song, Jeung Il Kim, Kyung Un Choi   +4 more
doaj   +1 more source

Supplementary Figure from Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors

, 2022
Supplementary Figure from Interactions in CSF1-Driven Tenosynovial Giant Cell ...
Michiel A.J. van de Sande (15052821), Kirsten van Langevelde (15052824), David G.P. van IJzendoorn (15052806), Judith V.M.G. Bovée (15038549), Sushama Varma (14864474), Deana R.C. Colburg (15052818), David G. Mohler (15052827), Geert Spierenburg (15052815), Gregory W. Charville (15052812), Matt van de Rijn (14864477), Robert B. West (15052839), Magdalena Matusiak (15052809), Raffi S. Avedian (15052833), Robert Steffner (15052836), Kristen N. Ganjoo (15052830), Nam Q. Bui (14958210)   +15 more
core   +1 more source

Recurrences (n = 50/63) of diffuse tenosynovial giant cell tumors (dTGCTs), and recurrences (n = 11/13) of localized tenosynovial giant cell tumors (lTGCTs).

, 2021
Recurrences (n = 50/63) of diffuse tenosynovial giant cell tumors (dTGCTs), and recurrences (n = 11/13) of localized tenosynovial giant cell tumors (lTGCTs).
N. Südkamp (11784963), M. Siegel (7632569), L. Bode (11784960), J. Kühle (11784966), H. Schmal (9138649), G. W. Herget (11784972), J. Zwingmann (11784969)   +6 more
core   +1 more source

Supplementary Table from Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors

, 2022
Supplementary Table from Interactions in CSF1-Driven Tenosynovial Giant Cell ...
Michiel A.J. van de Sande (15052821), Kirsten van Langevelde (15052824), David G.P. van IJzendoorn (15052806), Judith V.M.G. Bovée (15038549), Sushama Varma (14864474), Deana R.C. Colburg (15052818), David G. Mohler (15052827), Geert Spierenburg (15052815), Gregory W. Charville (15052812), Matt van de Rijn (14864477), Robert B. West (15052839), Magdalena Matusiak (15052809), Raffi S. Avedian (15052833), Robert Steffner (15052836), Kristen N. Ganjoo (15052830), Nam Q. Bui (14958210)   +15 more
core   +1 more source

PD-L1 Status in Tenosynovial Giant Cell Tumors

Medicina, 2022
Background and Objectives: Tenosynovial giant cell tumors (TSGCTs) are benign soft tissue tumors that are divided into localized- and diffuse-type tumors, according to the World Health Organization classification of soft tissue tumours. The diffuse-type TSGCT sometimes behave aggressively and poses treatment challenges especially in patients with ...
Tulay Zenginkinet, Abdullahi Umar Faruq, Ayse Nur Toksoz Yildirim, Yusuf Iyetin, Burak Ozturan, Erhan Okay, Aykut Celik, Korhan Ozkan, Muhlik Akyurek   +8 more
openaire   +3 more sources

Diagnostic Challenge of Localized Tenosynovial Giant Cell Tumor in Children. [PDF]

Diagnostics (Basel)
This report describes a rare case of a pediatric tenosynovial giant cell tumor (TSGCT) with a delayed diagnosis. A 9-year-old boy presented with a 3-month history of knee pain and swelling, initially attributed to a femoral non-ossifying fibroma and ...
Ichikawa J, Ochiai S, Kawasaki T, Onohara K, Wako M, Haro H, Hagino T.   +6 more
europepmc   +2 more sources

Tenosynovial, diffuse type giant cell tumor of the temporomandibular joint, diagnosis and management of a rare tumor [PDF]

, 2015
The purpose of this paper was to describe a rare unusual case of primary mandibular condylar tenosynovial giant cell tumor of diffuse type with predominantly intraosseous growth and its management by resection and functional reconstruction with a ...
Schucknecht, Bernhard, Bode-Lesniewska, Baete, Bernhard Schucknechtb, Baete Bode-lesniewskac, Bredell, Marius, Marius Bredella   +5 more
core   +1 more source